Are You Ready? DOACs for Pediatric Patients with Venous Thromboembolism
| Overview / Abstract: |
In this CME Touchpoint, leading pediatric cardiology expert, Riten Kumar, MD, MSc highlights the latest data on pediatric VTE and the role of DOACs. This interactive, engaging newsletter also expresses relevant dosing and administration considerations with the DOACs in the pediatric population. Clinicians need to stay abreast of the latest data with the DOACs in pediatric patients with or at risk for VTE. This education helps clinicians outline the epidemiology and risk factors of VTE in children, assess the most recent data with the DOACs for the pediatric population, and indicate current dosing and administration considerations with the DOACs in pediatric patients. |
|
Expiration |
Apr 29, 2023 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
|
Format |
Online |
|
Credits / Hours |
.50 AMA PRA Category 1 Credit™ |
|
Accreditation |
ACCME |
|
Presenters / Authors / Faculty |
Riten Kumar, MD, MSc |
|
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC. |
|
Keywords / Search Terms |
ACHL Riten Kumar, MD; CME Touchpoint; pediatric venous thromboembolism; pediatric VTE; pulmonary embolism; inherited thrombophilia; central venous catheter; direct oral anticoagulants; DOACs; dabigatran; rivaroxaban; apixaban; edoxaban; idarucizumab; andexanet alfa; deep vein thrombosis; DIVERSITY; Hokusai VTE PEDIATRICS study; EINSTEIN-Jr.; UNIVERSE; dabigatran oral pellets; rivaroxaban oral suspension; thromboprophylaxis Free CE CME |
|